On June 7, 2025, AB DAO announced that its native token $AB officially began trading on Binance Alpha-Binance's early-access, exclusive listing platform.

Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) ("Aura" or the "Company") announces that it has publicly filed a registration ...

DUBAI, AE / ACCESS Newswire / June 7, 2025 / Pi Protocol today announced the completion of its comprehensive rebrand to STBL, marking a strategic development that reflects the company's maturation to ...

SECAUCUS, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- The Children's Place, Inc. (Nasdaq: PLCE), the largest pure-play children's specialty retailer in North America with an omni-channel portfolio of ...

Japan Smaller Capitalization Fund, Inc. (the "Fund") (NYSE: JOF) today announced that its Board of Directors (the "Board") has approved two initiatives aimed ...

TYSONS CORNER, Va.--(BUSINESS WIRE)--Strategy (Nasdaq: MSTR/STRK/STRF) today announced the pricing of its initial public offering on June 5, 2025 of 11,764,700 shares of 10.00% Series A Perpetual ...

VANCOUVER, BC / ACCESS Newswire / June 6, 2025 / Empress Royalty Corp. (TSXV:EMPR)(OTCQX:EMPYF) ("Empress Royalty" or the "Company") announces that the Board of Directors has approved the granting of ...

Noah Holdings Limited (NOAH), along with its subsidiary ARK Wealth Management, unveiled its strategic wealth management framework at the 2025 Greenwich Economic Forum in Hong ...

OnePlus has officially introduced the Pad 3, marking its first tablet outside China powered by Qualcomm's top-tier Snapdragon 8 Gen 3 'Elite' chipset. Featuring a larger ...

Broadway Technology Inc ("Gaokai"), a leading manufacturer of high-quality PET (polyethylene terephthalate) cups and lids through its operating subsidiary ...

Dr. Shervin Naderi and his team integrate facial rejuvenation with weight loss care to manage the structural facial changes ...

PARIS (dpa-AFX) - French drug major Sanofi S.A. (SNYNF,SNY) announced Tuesday that the US Food and Drug Administration has granted orphan drug designation to rilzabrutinib for sickle cell disease.